NO953781L - Terapeutisk anvendelse av keratinocyttvekstfaktor - Google Patents

Terapeutisk anvendelse av keratinocyttvekstfaktor

Info

Publication number: NO953781L
Authority: NO; Norway
Prior art keywords: growth factor; therapeutic application; kgf; keratinocyte growth; vivo
Prior art date: 1993-03-26

Application number

NO953781A

Other languages

English (en)

Norwegian (no)

Other versions

NO953781D0 (no

Inventor

Glenn F Pierce

Regina M Housley

Charles F Morris

Original Assignee

Amgen Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-03-26

Filing date

1995-09-25

Publication date

1995-11-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21912689&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO953781(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-09-25 Application filed by Amgen Inc filed Critical Amgen Inc

1995-09-25 Publication of NO953781D0 publication Critical patent/NO953781D0/no

1995-11-27 Publication of NO953781L publication Critical patent/NO953781L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Gastroenterology & Hepatology (AREA)
Dermatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Immunology (AREA)
Zoology (AREA)
Biochemistry (AREA)
Mycology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Virology (AREA)
Toxicology (AREA)
Microbiology (AREA)
Genetics & Genomics (AREA)
Pulmonology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Cosmetics (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

NO953781A 1993-03-26 1995-09-25 Terapeutisk anvendelse av keratinocyttvekstfaktor NO953781L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US4074293A	1993-03-26	1993-03-26
PCT/US1994/003208 WO1994023032A1 (en)	1993-03-26	1994-03-24	Therapeutic uses of keratinocyte growth factor

Publications (2)

Publication Number	Publication Date
NO953781D0 NO953781D0 (no)	1995-09-25
NO953781L true NO953781L (no)	1995-11-27

Family

ID=21912689

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO953781A NO953781L (no)	1993-03-26	1995-09-25	Terapeutisk anvendelse av keratinocyttvekstfaktor

Country Status (23)

Country	Link
EP (1)	EP0619370B1 (ru)
JP (1)	JP3578761B2 (ru)
KR (1)	KR100390340B1 (ru)
CN (1)	CN1064710C (ru)
AT (1)	ATE183233T1 (ru)
AU (1)	AU707340B2 (ru)
CA (1)	CA2159109C (ru)
CZ (1)	CZ285996B6 (ru)
DE (1)	DE69419958T2 (ru)
DK (1)	DK0619370T3 (ru)
ES (1)	ES2136673T3 (ru)
FI (1)	FI954541A7 (ru)
GR (1)	GR3031509T3 (ru)
HU (1)	HU220641B1 (ru)
IL (4)	IL109122A (ru)
NO (1)	NO953781L (ru)
NZ (1)	NZ263967A (ru)
RU (1)	RU2146148C1 (ru)
SG (1)	SG49841A1 (ru)
SI (1)	SI0619370T1 (ru)
SK (1)	SK281674B6 (ru)
UA (1)	UA46706C2 (ru)
WO (1)	WO1994023032A1 (ru)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AUPN271295A0 (en) *	1995-05-02	1995-05-25	Gropep Pty Ltd	Method of treatment
SI0804479T1 (sl) *	1994-10-13	2006-12-31	Amgen Inc	Metoda zdravljenja sladkorne bolezni z uporabo kgf
WO1996025422A1 (en) *	1995-02-14	1996-08-22	Human Genome Sciences, Inc.	Keratinocyte growth factor-2
US6693077B1 (en)	1995-02-14	2004-02-17	Human Genome Sciences, Inc.	Keratinocyte growth factor-2
US6077692A (en)	1995-02-14	2000-06-20	Human Genome Sciences, Inc.	Keratinocyte growth factor-2
US7232667B2 (en)	1995-02-14	2007-06-19	Human Genome Sciences, Inc.	Keratinocyte growth factor-2 polynucleotides
DE69637332T2 (de) *	1995-10-11	2008-10-09	Novartis Vaccines and Diagnostics, Inc., Emeryville	Kombinierung von PDGF, KGF, IGF und IGFBP für Wundheilung
GB9619660D0 (en) *	1996-09-20	1996-11-06	Scient Hospital Suppl Int Ltd	Prevention of gastrointestinal damage
SI0941110T1 (en) *	1996-10-15	2004-06-30	Amgen Inc.	Uses of keratinocyte growth factor-2
ES2216134T3 (es) *	1996-10-15	2004-10-16	Amgen Inc.	Utilizaciones del factor de crecimiento de los queratinocitos 2)(kgf-2).
US6743422B1 (en)	1996-10-15	2004-06-01	Amgen, Inc.	Keratinocyte growth factor-2 products
US20010006939A1 (en) *	1997-10-03	2001-07-05	Ralph W. Niven	Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions
US6228839B1 (en) *	1997-12-19	2001-05-08	Emory University	Use of keratinocyte growth factor to improve oxidative status
US6869927B1 (en)	1997-12-22	2005-03-22	Human Genome Sciences, Inc.	Keratinocyte growth factor-2 formulations
KR20010033484A (ko)	1997-12-22	2001-04-25	휴먼 게놈 사이언시즈, 인크.	각질세포 성장 인자-2 제제
CN1295579A (zh)	1998-02-13	2001-05-16	人类基因组科学公司	角质细胞生长因子2的治疗应用
US6335317B1 (en)	1998-04-10	2002-01-01	Emory University	Use of gut-trophic growth factors to improve oxidative status
MY124799A (en)	2000-03-20	2006-07-31	Pfizer Prod Inc	Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor
BR0207017A (pt) *	2001-02-06	2004-02-03	Merck Patent Gmbh	Fator de crescimento ceratinócito modificado (kgf) com imunogenicidade reduzida
US7202066B2 (en)	2002-01-29	2007-04-10	Carrington Laboratories, Inc.	Combination of a growth factor and a protease enzyme
RU2243784C2 (ru) *	2003-02-25	2005-01-10	Козлов Владимир Александрович	Способ лечения больных хроническим гепатитом
EP1789138A2 (en) *	2004-09-13	2007-05-30	University Of Southampton	Growth factor treatment for asthma
RU2391990C1 (ru) *	2008-11-25	2010-06-20	Александр Сергеевич Ботин	Композиция для стимулирования роста и регенерации клеток, (варианты), а также способ ее получения (варианты)
CN101822821B (zh) *	2010-04-27	2013-01-23	复旦大学附属中山医院	角质细胞生长因子-2在制备防治肺损伤的药物中的应用
CN104707164B (zh) *	2015-03-31	2017-01-18	中国人民解放军军事医学科学院基础医学研究所	一种复合壳聚糖水凝胶敷料及其制备方法和应用
CN106226511B (zh) *	2016-07-28	2018-04-06	苏州金盟生物技术有限公司	一种重组人角质细胞生长因子生物学活性检测方法
CN107753932A (zh) *	2016-08-22	2018-03-06	中国辐射防护研究院	Kgf在制备治疗或预防放射性肠炎药物中的用途
WO2020111047A1 (ja)	2018-11-27	2020-06-04	株式会社海月研究所	頭皮頭髪用組成物
KR20210114646A (ko) *	2020-03-11	2021-09-24	(주)메디코스바이오텍	성장인자를 함유하는 탈모 치료 또는 모발 성장 촉진용 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2250213C2 (ru) *	1989-01-31	2005-04-20	Джеффри С. РУБИН	Выделенный белок фактора роста кератиноцита (kgf), рекомбинантная молекула днк, вектор, способ конструирования клетки-хозяина, способ получения белка, фармацевтическая композиция
JPH04224522A (ja) *	1990-04-27	1992-08-13	Merck & Co Inc	繊維芽細胞増殖因子含有組成物による禿頭症の治療又は予防方法
WO1992014480A1 (en) *	1991-02-22	1992-09-03	Amgen Inc.	Use of gm-csf and g-csf to promote accelerated wound healing

1994
- 1994-03-24 IL IL10912294A patent/IL109122A/en not_active IP Right Cessation
- 1994-03-24 CN CN94192037A patent/CN1064710C/zh not_active Expired - Lifetime
- 1994-03-24 UA UA95104698A patent/UA46706C2/uk unknown
- 1994-03-24 WO PCT/US1994/003208 patent/WO1994023032A1/en not_active Ceased
- 1994-03-24 IL IL137581A patent/IL137581A/en not_active IP Right Cessation
- 1994-03-24 FI FI954541A patent/FI954541A7/fi unknown
- 1994-03-24 JP JP52218894A patent/JP3578761B2/ja not_active Expired - Lifetime
- 1994-03-24 CZ CZ952482A patent/CZ285996B6/cs not_active IP Right Cessation
- 1994-03-24 CA CA002159109A patent/CA2159109C/en not_active Expired - Lifetime
- 1994-03-24 KR KR1019950704154A patent/KR100390340B1/ko not_active Expired - Lifetime
- 1994-03-24 RU RU95117959A patent/RU2146148C1/ru active
- 1994-03-24 NZ NZ263967A patent/NZ263967A/en not_active IP Right Cessation
- 1994-03-24 AU AU65243/94A patent/AU707340B2/en not_active Expired
- 1994-03-24 HU HU9502800A patent/HU220641B1/hu unknown
- 1994-03-24 SK SK1185-95A patent/SK281674B6/sk not_active IP Right Cessation
- 1994-03-25 DE DE69419958T patent/DE69419958T2/de not_active Expired - Lifetime
- 1994-03-25 SI SI9430265T patent/SI0619370T1/xx unknown
- 1994-03-25 ES ES94104804T patent/ES2136673T3/es not_active Expired - Lifetime
- 1994-03-25 DK DK94104804T patent/DK0619370T3/da active
- 1994-03-25 AT AT94104804T patent/ATE183233T1/de active
- 1994-03-25 SG SG1996007376A patent/SG49841A1/en unknown
- 1994-03-25 EP EP94104804A patent/EP0619370B1/en not_active Expired - Lifetime
1995
- 1995-09-25 NO NO953781A patent/NO953781L/no not_active Application Discontinuation
1999
- 1999-10-13 GR GR990402604T patent/GR3031509T3/el unknown
2000
- 2000-07-30 IL IL13758100A patent/IL137581A0/xx unknown
2004
- 2004-04-22 IL IL16156804A patent/IL161568A0/xx unknown

Also Published As

Publication number	Publication date
HUT72711A (en)	1996-05-28
CZ248295A3 (en)	1996-12-11
IL137581A0 (en)	2001-07-24
IL109122A0 (en)	1994-06-24
ES2136673T3 (es)	1999-12-01
SI0619370T1 (en)	1999-10-31
CZ285996B6 (cs)	1999-12-15
IL109122A (en)	2004-07-25
EP0619370B1 (en)	1999-08-11
FI954541L (fi)	1995-11-23
SK118595A3 (en)	1996-11-06
WO1994023032A1 (en)	1994-10-13
KR100390340B1 (ko)	2003-09-26
CN1217022A (zh)	1999-05-19
CA2159109A1 (en)	1994-10-13
SK281674B6 (sk)	2001-06-11
DK0619370T3 (da)	2000-02-28
CA2159109C (en)	2004-11-16
EP0619370A1 (en)	1994-10-12
RU2146148C1 (ru)	2000-03-10
JP3578761B2 (ja)	2004-10-20
NZ263967A (en)	2005-02-25
IL137581A (en)	2009-09-01
DE69419958D1 (de)	1999-09-16
AU6524394A (en)	1994-10-24
UA46706C2 (uk)	2002-06-17
AU707340B2 (en)	1999-07-08
FI954541A7 (fi)	1995-11-23
FI954541A0 (fi)	1995-09-25
HU9502800D0 (en)	1995-12-28
HU220641B1 (hu)	2002-03-28
ATE183233T1 (de)	1999-08-15
DE69419958T2 (de)	2000-04-20
CN1064710C (zh)	2001-04-18
GR3031509T3 (en)	2000-01-31
IL161568A0 (en)	2004-09-27
NO953781D0 (no)	1995-09-25
SG49841A1 (en)	1998-06-15
KR960701204A (ko)	1996-02-24
JP2002526026A (ja)	2002-08-13

Publication	Publication Date	Title
NO953781L (no)	1995-11-27	Terapeutisk anvendelse av keratinocyttvekstfaktor
BORA JR et al.	1972	Inhibitors of collagen biosynthesis as a means of controlling scar formation in tendon injury
BRPI0412526A (pt)	2006-09-19	composto, uso de um composto, composição farmacêutica, formulação em aerossol farmacêutica, e, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica
ATE308545T1 (de)	2005-11-15	Chlorophyll- und bacteriochlorophyllester, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
DK1007566T3 (da)	2007-01-02	Terapeutisk anvendelse af SMR1-protein og aktive derivater deraf
Laato et al.	1986	Effect of epidermal growth factor (EGF) on experimental granulation tissue
ATE259651T1 (de)	2004-03-15	Verwendung von keratinocyten-wachstumsfaktor-2
DE69328527D1 (de)	2000-06-08	Carboxypeptidase-ähnliches Protein aus Knochen und Verfahren zur dessen Herstellung
DK1165102T3 (da)	2004-06-01	Matrixproteinpræparater til podning i ikke-mineraliseret væv
NO933742L (no)	1993-10-18	Humant, benavledet, insulinlignende vekstfaktorbindingsprotein
ATE428438T1 (de)	2009-05-15	Tcf-ii enthaltende medizinische zusammensetzung
ES2167322T3 (es)	2002-05-16	Proteina de tipo cadherinico relacionada con los huesos y procedimiento para su preparacion.
KR100488038B1 (ko)	2005-05-09	기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
Zhao et al.	1991	Autoradiographic localization of endothelin-1 binding sites in porcine skin
Jalil	2019	The Influence of Anisotropic Tissue Expander on Nestin and Trkb Expression in Rat Cranio-facial Region.
Bush	2009	The Effects of Wound Mechanical Factors and Intradermal Transforming Growth Factor β3 Application on the Outcome of Cutaneous Scars
Jain et al.	2007	Evaluation of Wound Healing Activity of Herbal Formulation
Tabata	2005	Regenerative Medical Therapy for Hard Tissues Based on Tissue Engineering
UA14207U (en)	2006-05-15	Technique for indirect vascularization of lower limb

Legal Events

Date	Code	Title	Description
2005-10-17	FC2A	Withdrawal, rejection or dismissal of laid open patent application